Information about ImmuneSpec
My details
*
*
*

ImmuneSpec (SRL)

BE 0797.707.610

Galileilaan 18/6, 2845 Niel

Company information

Status
Active

Enterprise number

BE0797.707.610

VAT liability
Yes
Established
27-01-2023
Last balance sheet year
2025
Company size
Medium-sized 5,7 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from ImmuneSpec

2025 2024 2023
Profit/Loss € -201,723 -159 % € -77,917 80 % € -397,068
Equity € 2,638,403 13 % € 2,340,065 22 % € 1,917,922
Gross margin € 883,559 27 % € 696,858 1252 % € 51,531
Employees 5.7 3.4 1.7

Publications from ImmuneSpec

Date Publication
06-05-2026 Resignations - Appointments (NL)
24-03-2025 Capital - Shares (NL)
19-09-2024 Resignations - Appointments (NL)
06-06-2024 Capital - Shares (NL)
28-03-2024 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of ImmuneSpec?
The VAT number of ImmuneSpec is BE 0797.707.610.
Wat is the PEPPOL ID of ImmuneSpec?
The PEPPOL ID of ImmuneSpec is 0208:0797707610. Log in or start a free trial to see the full overview.
When was ImmuneSpec founded?
ImmuneSpec was founded on 27-01-2023.
What is the address of ImmuneSpec?
The current registered office of ImmuneSpec is located at Galileilaan 18/6, 2845 Niel.
When was the last time ImmuneSpec filed their annual financial statements?
The most recent financial statements of ImmuneSpec were filed on 09-06-2026.
How many employees does ImmuneSpec have?
There are 5,7 FTEs working at ImmuneSpec according to the staff figures in the most recent financial statements.
What is the annual turnover of ImmuneSpec?
At the time of its most recent financial statements, ImmuneSpec did not publish any turnover figures. ImmuneSpec reported a gross margin of €883,559.25.

Sources